Aclaris Therapeutics announced positive results from a phase 3 trial investigating a proprietary formulation of hydrogen peroxide (A-101) for the topical treatment of common warts. Aclaris ...
The company expects to begin the final stage of testing for its experimental common warts treatment during the second half of this year. Aclaris Therapeutics Inc. said Monday its experimental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results